Metapain (nefopam/paracetamol) / Aptys Pharma - LARVOL DELTA

Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction (clinicaltrials.gov) - P3 | N=321 | Completed | Sponsor: Unither Pharmaceuticals, France | Active, not recruiting ➔ Completed

Trial completion • Pain

Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction (clinicaltrials.gov) - P3 | N=321 | Active, not recruiting | Sponsor: Unither Pharmaceuticals, France | Recruiting ➔ Active, not recruiting

Enrollment closed • Pain

APTYS PHARMA (BIO 2022) - "Loramyc® and Testocream® are based on Aptys pharma technologies...Our clients come to us because we can solve formulation problems and make from a bright idea an industrial reality because our team is made of flexible and open mind scientists. At the end Aptys can deliver a ready-to-use package: formula + recipe + validated analytical methods + stability data."

Pain

Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction (clinicaltrials.gov) - P3 | N=321 | Recruiting | Sponsor: Unither Pharmaceuticals, France | Trial completion date: Jul 2022 ➔ Oct 2022 | Trial primary completion date: May 2022 ➔ Oct 2022

Trial completion date • Trial primary completion date • Pain